Russell Frank Company’s Genomic Health, Inc. GHDX Stock Holding History

Russell Frank Company’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.54M	Buy	102,387 +2,633	+3%	+$72.3K	﹤0.01%	1726
2015 Q4	$3.52M	Buy	99,754 +76,416	+327%	+$2.05M	0.01%	1484
2015 Q3	$494K	Buy	23,338 +10,486	+82%	+$270K	﹤0.01%	2479
2015 Q2	$357K	Buy	+12,852	New	+$363K	﹤0.01%	2680
2013 Q4	–	Sell	-85	Closed	-$3K	–	3195
2013 Q3	$3K	Sell	85 -15	-15%	-$502	﹤0.01%	3350
2013 Q2	$3K	Buy	+100	New	+$3.28K	﹤0.01%	3158

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Russell Frank Company's GHDX Position: Q1 2016 in Review

Russell Frank Company increased its Genomic Health, Inc. (GHDX) stake by 2.6% in Q1 2016, buying an estimated $72.3K and bringing the position to 102,387 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1726.

Russell Frank Company first reported a position in GHDX in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.52M in Q4 2015. 127 funds tracked by Wall St. Rank hold GHDX as of Q1 2016.

Russell Frank Company held 102,387 shares of Genomic Health, Inc. worth $2.54M as of Q1 2016.
Russell Frank Company bought 2,633 Genomic Health, Inc. shares in Q1 2016, an estimated $72.3K.
Genomic Health, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1726 holding.
Russell Frank Company first reported a position in Genomic Health, Inc. in Q2 2013 and has held it in 6 quarters since.
Russell Frank Company's Genomic Health, Inc. position peaked at $3.52M in Q4 2015.
127 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.